— Know what they know.
Not Investment Advice

GTH NASDAQ

Genetron Holdings Limited
1W: +0.5% 1M: +3.3% 3M: +9.5% 1Y: +34.3% 3Y: -92.6%
$4.03
Last traded 2024-03-28 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $127.3M mcap · 215M float · 0.024% daily turnover

Balance Sheet Trends

Total Assets
$975M -35.7% ▼
5Y CAGR: +17.2%
Total Liabilities
$427M +38.8% ▲
5Y CAGR: -16.7%
Shareholders Equity
$546M -54.7% ▼
Cash & Investments
$334M -57.8% ▼
5Y CAGR: +2.5%
Total Debt
$159M +114.3% ▲
Net Debt
-$18M +96.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$62M$140M$1.4B$639M$176M
Short-Term Investments$39M$122M$140M$151M$157M
Cash & ST Investments$101M$262M$1.5B$790M$334M
Net Receivables$71M$105M$208M$388M$323M
Inventory$22M$18M$25M$36M$42M
Other Current Assets$37M$44M$36M$31M$9M
Total Current Assets$231M$429M$1.8B$1.2B$709M
Property, Plant & Equip.$83M$126M$137M$162M$178M
Goodwill & Intangibles$3M$5M$12M$21M$32M
Long-Term Investments$0$0$20M$50M$50M
Other Non-Current Assets$8M$13M$15M$38M$6M
Total Non-Current Assets$94M$144M$184M$270M$266M
Total Assets$324M$574M$2.0B$1.5B$975M
— Liabilities —
Accounts Payable$12M$50M$34M$56M$63M
Short-Term Debt$929K$35M$75M$40M$131M
Deferred Revenue$9M$18M$8M$12M$22M
Other Current Liabilities$55M$110M$111M$157M$174M
Total Current Liabilities$68M$213M$229M$265M$390M
Long-Term Debt$0$33M$49M$34M$27M
Other Non-Current Liab.$1.3B$2.1B-$49M$9M$10M
Total Non-Current Liabilities$1.3B$2.1B$49M$42M$37M
Total Liabilities$1.4B$2.4B$277M$308M$427M
— Equity —
Common Stock$0$17K$59K$61K$61K
Retained Earnings-$1.2B-$1.8B-$4.9B-$5.4B-$6.2B
Accumulated OCI$112M$69M-$4M-$69M$56M
Total Stockholders Equity-$1.1B-$1.8B$1.7B$1.2B$546M
Total Liabilities & Equity$324M$574M$2.0B$1.5B$975M
— Key Metrics —
Total Debt$0$68M$124M$74M$159M
Net Debt-$62M-$72M-$1.3B-$565M-$18M
Total Investments$39M$122M$160M$201M$208M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms